液基细胞学检查在宫颈疾病中的诊断价值  

The diagnostic value of thinprep cytological test in cervical disease

作　　者：周毅惠[1] 何莲芝[1] 朱珠[1] 施素华[1] 周银燕[1] 

机构地区：[1]皖南医学院弋矶山医院妇产科,芜湖241001

出　　处：《安徽医学》2010年第7期746-748,共3页Anhui Medical Journal

摘　　要：目的探讨液基超薄细胞技术(thinprep cytologic test,TCT)和Bethesd系统(TBS)在早期宫颈病变诊断中的临床价值。方法 2 187例患者进行TCT检查和TBS细胞学分类诊断,对TCT检查发现异常者行病理检查。结果 2 187例TCT中检出细胞学异常的139例,其中不典型鳞状细胞(ASC)93例,低度鳞状上皮内病变(LSIL)22例,高度鳞状上皮内病变(HSIL)24例。大于55岁年龄段,细胞学阳性检出率最高,其次是36～45岁年龄段;TCT与病理检查符合率分别为ASCUS 69.64%、LSIL 45.45%、HSIL94.44%。结论 TCT技术结合TBS应用于宫颈细胞学涂片配合阴道镜下活检是筛查和诊断子宫颈癌前病变的有效手段。Objective Discuss the clinical value of thinprep cytological test in diagnosis of early cervical disease.Methods 2187 patientshad TCT examine and TBS cell classify,and pathological examine were applied to the patients who had abnormal TCT results.Results Of 139 patients who had TCT abnormal results,ASC in 93,LSIL in 22,and HSILin 24.People over 55 years old had the highest cell positive rate,nextpeople aged36 to 45 years old TCT results and pathology results accordance rates were as follow： ASCUS 69.64%,HSIL94.44%,and LSIL 45.45%.Conclusion TCT examine and TBS applied to cervical cell examine and vaginal spectacles examine can be used to screen and diagnosis precabcerous lesions of cervical cancer.

关 键 词：液基超薄细胞技术 Bethesd系统 阴道镜 病理活检 

分 类 号：R737.33[医药卫生—肿瘤]